Alvarez RD - Search Results

1

Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I study.

Meredith RF, Alvarez RD, Partridge EE, Khazaeli MB, Lin CY, Macey DJ, Austin JM Jr, Kilgore LC, Grizzle WE, Schlom J, LoBuglio AF. Meredith RF, et al. Among authors: alvarez rd. Cancer Biother Radiopharm. 2001 Aug;16(4):305-15. doi: 10.1089/108497801753131381. Cancer Biother Radiopharm. 2001. PMID: 11603001 Clinical Trial.

2

Predictors of long-term outcome from intraperitoneal radioimmunotherapy for ovarian cancer.

Meredith R, You Z, Alvarez R, Partridge E, Grizzle W, LoBuglio A. Meredith R, et al. Cancer Biother Radiopharm. 2012 Feb;27(1):36-40. doi: 10.1089/cbr.2011.1111. Epub 2012 Jan 12. Cancer Biother Radiopharm. 2012. PMID: 22239432 Free PMC article.

3

Pharmacokinetics and imaging of 212Pb-TCMC-trastuzumab after intraperitoneal administration in ovarian cancer patients.

Meredith RF, Torgue J, Azure MT, Shen S, Saddekni S, Banaga E, Carlise R, Bunch P, Yoder D, Alvarez R. Meredith RF, et al. Cancer Biother Radiopharm. 2014 Feb;29(1):12-7. doi: 10.1089/cbr.2013.1531. Epub 2013 Nov 14. Cancer Biother Radiopharm. 2014. PMID: 24229395 Free PMC article. Clinical Trial.

4

A Phase I study of combined modality (90)Yttrium-CC49 intraperitoneal radioimmunotherapy for ovarian cancer.

Alvarez RD, Huh WK, Khazaeli MB, Meredith RF, Partridge EE, Kilgore LC, Grizzle WE, Shen S, Austin JM, Barnes MN, Carey D, Schlom J, LoBuglio AF. Alvarez RD, et al. Clin Cancer Res. 2002 Sep;8(9):2806-11. Clin Cancer Res. 2002. PMID: 12231520 Clinical Trial.

5

Brief overview of preclinical and clinical studies in the development of intraperitoneal radioimmunotherapy for ovarian cancer.

Meredith RF, Buchsbaum DJ, Alvarez RD, LoBuglio AF. Meredith RF, et al. Among authors: alvarez rd. Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5643s-5645s. doi: 10.1158/1078-0432.CCR-07-0985. Clin Cancer Res. 2007. PMID: 17875801 Review.

6

Response to salvage treatment in recurrent ovarian cancer treated initially with paclitaxel and platinum-based combination regimens.

Roland PY, Barnes MN, Niwas S, Robertson MW, Alvarez R, Austin JM, Kilgore LC, Partridge EE. Roland PY, et al. Gynecol Oncol. 1998 Feb;68(2):178-82. doi: 10.1006/gyno.1997.4909. Gynecol Oncol. 1998. PMID: 9514799

7

The Groshong catheter as an intraperitoneal access device in the treatment of ovarian cancer patients.

Naumann RW, Alvarez RD, Partridge EE, Kilgore LC, Austin JM. Naumann RW, et al. Among authors: alvarez rd. Gynecol Oncol. 1993 Sep;50(3):291-3. doi: 10.1006/gyno.1993.1213. Gynecol Oncol. 1993. PMID: 8406189

8

Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49.

Meredith RF, Partridge EE, Alvarez RD, Khazaeli MB, Plott G, Russell CD, Wheeler RH, Liu T, Grizzle WE, Schlom J, LoBuglio AF. Meredith RF, et al. Among authors: alvarez rd. J Nucl Med. 1996 Sep;37(9):1491-6. J Nucl Med. 1996. PMID: 8790200 Free article. Clinical Trial.

9

Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II study.

Alvarez RD, Partridge EE, Khazaeli MB, Plott G, Austin M, Kilgore L, Russell CD, Liu T, Grizzle WE, Schlom J, LoBuglio AF, Meredith RF. Alvarez RD, et al. Gynecol Oncol. 1997 Apr;65(1):94-101. doi: 10.1006/gyno.1996.4577. Gynecol Oncol. 1997. PMID: 9103398 Clinical Trial.

10

A phase I study of paclitaxel, doxorubicin, and cisplatin in patients with previously untreated epithelial ovarian cancer.

Naumann RW, Alvarez RD, Omura GA, Segars E, Kilgore LC, Partridge EE. Naumann RW, et al. Among authors: alvarez rd. Gynecol Oncol. 1998 Dec;71(3):450-3. doi: 10.1006/gyno.1998.5205. Gynecol Oncol. 1998. PMID: 9887248 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters